Calidi Biotherapeutics investor webinar
Analysis based on 7 articles · First reported Jun 05, 2026 · Last updated Jun 08, 2026
The investor webinar by Atara Biotherapeutics, hosted by RedChip Companies, aims to inform investors about its RedTail platform and CLD-401 candidate. This could positively impact Atara Biotherapeutics' stock price by increasing investor awareness and confidence in its pipeline and future milestones.
Atara Biotherapeutics, a biotechnology company, is participating in an investor webinar hosted by RedChip Companies on June 9, 2026. Eric Poma, CEO of Atara Biotherapeutics, will present an in-depth overview of the company's breakthrough RedTail platform, a next-generation targeted virotherapy, and its lead candidate, CLD-401. The discussion will cover progress towards IND submission, preclinical data, upcoming development milestones, and the broader potential of the RedTail platform across oncology and other disease areas. A live Q&A session will follow the presentation, allowing investors to submit questions.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard